Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare LlcfiledCriticalBayer Healthcare Llc
Publication of MY140832ApublicationCriticalpatent/MY140832A/en
Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Pyridine Compounds
(AREA)
Abstract
THIS INVENTION RELATES TO NOVEL DIARYL UREAS, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH COMPOUNDS AND THE USE OF THOSE COMPOUNDS OR COMPOSITIONS FOR TREATING HYPER-PROLIFERATIVE AND ANGIOGENESIS DISORDERS, AS A SOLE AGENT OR IN COMBINATION WITH CYTOTOXIC THERAPIES.
MYPI20040669A2003-02-282004-02-27Novel cyanopyridine derivatives useful in the treatment of cancer and other disorders
MY140832A
(en)
Pyrazole derivatives, pharmaceutical compositions containing them and use thereof in the manufacture of medicaments for treatment and prevention of cancers
Pyrazole derivatives, pharmaceutical compositions containing them and use thereof in the manufacture of medicaments for treatment and prevention of cancers